# SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-29 00:29 UTC · Category: Health · Sources: 10 · Current Velocity: 9.49

## Intelligence Brief
"SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke" developed substantial multi-source reporting across the Health sector, tracked across 10 distinct newsrooms by Newsylist.


Key reporting was led by en.sedaily.com, Korea Biomedical Review, medscape.com and News-Medical. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermed?
Coverage spiked when 10 independent newsrooms published 12 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| en.sedaily.com | Blood Thinners Cut Stroke Risk in Moderate-Risk Heart Patients | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPYlVESDZhRHJUeTVVZ1I1U1NoMDNWVnM5TmRMV2VnaU4wUEpfcWlnUTBYNjYycWxQeDBjeU85WUpabEpmcUVnWFl0OUsxejRpczFDSXU1OVZhN3BSSEd1LUJ5dWVHb1NfR3pYM2JFSDBKQlFxdFRGY194aFcwSElYSHE4OUI5ZnAxWGhaaXV3ck9jM0laNGNPSkxYMA?oc=5) |
| Korea Biomedical Review | [ESC 2026] SINGLE-AF study closes evidence gap on DOACs in intermediate-risk AF | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMibkFVX3lxTE9jOVQ0Z200end6WWNEcFR1YnVqVkFVNmpMbzdib3c5aVhNOVFYSGd4b0I0VTV0RzhWd1JndmRTZHhxc2JUNy1HZXdJdUdZT0RrSldoSVI1alRqYkNDSHVEVkdSU21BS0pKdDRlcW5n0gFyQVVfeXFMUDBKa3Q5V1hKN2twaHhTRUVPQjFQam11YzdIMENxTUp0Zi1SZXQwcjU3MkFVVGRmN3BWNGs2Q01zMEdqNlY4ODdOZWJHTXdCc2ZTMVNJOUNIYThPWC1SdFl6bS1vVHJoMVBvVTFGYXg0azdR?oc=5) |
| medscape.com | To Anticoagulate or Not in Intermediate-Risk AF: The SINGLE-AF Trial | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNR1hGS25jUmFvVjV2S0pxNjd2cnc0eGdlbVd2M0FKNFFnYTRZNlJ6dTNrODdOM3JGeE9MQ2pzS1pXSDh4UHNQb2hvVnBQeWVReEFPOXMtMEFxa3JvMGRQUnhjQWZFa1p4QmlxY18yVUlGdkNtSEp1eExhVldmRERSSFl0Y0NOWnFjQXBlRGx5ZmlOSHhyTzV6Vy1HN2ZqXzNEam0xTk4tM0lZM00?oc=5) |
| News-Medical | New findings do not support the use of edoxaban in AF patients after intracranial hemorrhage | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaE9WOU9IcGFzd2ozMkQ4UHBIS19ZTzh3MmplbWpHd0xnRmdJLWg0UC10NlJMUTd6b0htemk2amVsT1Q4aVBhZk51cEZqejk5UHJxbDZlRnpEX2ZCa2JlUzJHVTFaa3VJWU5GM1NxX0dKYmdoaVZMZFZYREYxZW15MnVFLVNEcWVfM05NT0pWVU9oS1dJYUNyQmZlUEFnMi13UUw0TnduTC1oYk1OcW1naVZqanZxNnpUQTNSdkxaR2g3bjRLZDRmTDUyV2V0M3IwRE1mc25Ibw?oc=5) |
| HCPLive | ENRICH-AF: Edoxaban Increases Bleeding Without Reducing Stroke | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxNZEpxYkpFNjNDb2JXSzE1TC1UQWNBMFFGcUJwZ01oUTZNeHNYbXFMNHgwSmpNNWZNMlNNZldEc0JNbi01djVIWDZGbDAtZXdzSTlnLVExYl9PMXRaYlhpbjJwRmlDaGlITVhGYUVIckJkelMzOURLTXdqS3pVMFRlNm1QT0w1SDNVdUhDSGtpTnozeUNR?oc=5) |
| Medical Xpress | People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNaTZOR09WbzhlbkhtVDM5MEIybWlPVHBQWmdOS1ltNmV5akZvZUpVOU9aby1zY19fZndIb0hmYzF2QVJkRkVsTmJyeGVYWE9aaGZOTlpraVRFWEhGTEtGWXhQbzJwaVFGVFpyQXd1czBMSkxNYXV1VDJULUVVTWVQTTJ1WTJjRGdDUE1nZUxEOTNoTk15Rmc?oc=5) |
| TCTMD.com | DOACs Benefit AF Patients With Intermediate Stroke Risk: SINGLE-AF | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxPLW1XcU5qUmFaOHZfVkhueGFPOUZZcXlRY1BxUDhNckxRWV83SmdBQ094bEczeXF0akgzOGh4ZnZaYU1MUDlUU29YVmlzZFNkX2ExbVdodUZrSlpYdS1TR2FiQjhKaFZSYjlDVmtwV000UnEyc25Qa2FXSnE1OGRWLVRKVEtsdmlobXZSaS1qM04?oc=5) |
| MedPage Today | First Major Trial Win for Contemporary DOACs in Lower-Risk Afib | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMiZkFVX3lxTFA0YVVDZHN2SFV1eFczVG9oanQ3TEFSQVV4OGNxS0xRWVlwMXhOajhLX0VzRUxyLXhuSzk0SHE5eXZDQzZZZzJoTktFU0dibGtfeEFkU3M0NHNpWkdydFkyMWp2Ym5XUQ?oc=5) |
| HCPLive | SINGLE-AF: Oral Anticoagulants Reduce Risk of Stroke in Patients With AF | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxObWlqbHZaYmVpWDhlYXNOUTJlY0FXZVE4a1E0WHkxN2N6WG56ZzNDMjBpck5xbWdWWWFVQ3pGUkUyT0FzeFdLbzFOUlFUUnJRSGkzOGdBdldpS052c0pka1Vid2lUN2xwOEJnbG1IaE1ZWlBzUWRuRzRFRVI5ekFidG9rejNkYVNJZ3ZmTW1tMGZOSEtJRm1hZGFUMkttVVVYUnc?oc=5) |
| News-Medical | Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZU1USTdaOWJuYjZILVVKTkFaZHBaT2RuQ0xPVE1kSjdoX1dsMmVaNVI4U0ozTnl4cmVSZkJCakFCX0R4Y0ZmNVBGT1lmUFlpWklJSXU2ZFNBd3Z4NUJFT3BFakl4emo4c0FqUm5VREVQck5jZEQ2MG00UGhSeHVPU3k0M0JfbDkzSUtpSGc1Z3VMUExyNXh5QUVaR2NOc3hGRTVuTVdaamNVa3puVklnWUpaZGZ2SVFoVWlxOUVBcWwzV2lKZDFhazAwN2p1eWUzQWc4?oc=5) |
| Medscape | DOACs Benefit AF Patients With Intermediate Stroke Risk | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPRDhoekF4SkxzWlZMY2ZBOHowUkMycUhncDJNRVBFM1JNOFV1QTQybXlNRDlGMGN6NWplMkpvZVN0TVdmYVpRNFkwOEpVUXpkOHZ6X0xHR1NCOWoyWHVDbnJ1ZUprZzJjN01WSXdrS1g3d0psN1hvWkY1NV84ZVFLTmZraENHdU94Ry11XzRHclVsdGx3NWVDdmM4T18wR1NFOXVhSVJhZlNNcmdmSmp3?oc=5) |
| American College of Cardiology | SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke | 2026-08-28 11:48 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPd0xVTjhMblBZbW1UaWhFd0pCTEZ0QUt2WHhSY1F0Z2hmeS1DWUJEVjdFN2xoM09XRlBDZW82VGIyOGFySHh3WE9rZmhQdE5RakFqdlFDSDJJSzVQendWdnU5dDFBMlVOcVVFMGxLTXI3cmlDQmlCYWNPc01qYnZkYlZxT05rYWNqZWY1ci1SR010X0VyOWJmd0FTdw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-29/single-af-doac-therapy-vs-no-anticoagulation-in-afib-patients-at-intermediate*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*